Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis

PURPOSE: The aim of this study was to investigate the comparative risks of budesonide/formoterol, versus placebo or monotherapies, for the treatment of patients with stable COPD. MATERIALS AND METHODS: We undertook a systematic search of the literature in PubMed, Embase, and the Cochrane Central Reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bin, Wang, Jun, Luo, Lin-lin, Li, Qiu-gen, Huang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448539/
https://www.ncbi.nlm.nih.gov/pubmed/31015757
http://dx.doi.org/10.2147/COPD.S192166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448539/
https://www.ncbi.nlm.nih.gov/pubmed/31015757
http://dx.doi.org/10.2147/COPD.S192166

Ejemplares similares